Coherus Biosciences | Devedores Comerciais

Preço das Ações
2.15
Mudança Diária
0.09 4.13%
Mensal
30.00%
Anual
93.24%
Q1 Previsão
2.39




Devedores Comerciais Alterar Data
AbbVie USD 12.77B 132M 2025-09
Acadia Pharmaceuticals USD 139.44M 19.75M 2025-09
Akebia Therapeutics USD 61.54M 27.17M 2025-03
ALKERMES USD 355.11M 1.22M 2025-09
Alnylam Pharmaceuticals USD 964.77M 397.66M 2025-09
Amarin USD 127.31M 8.18M 2025-09
Amgen USD 9.57B 1.08B 2025-12
Baxter International USD 1.77B 127M 2025-06
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 790.27M 65.59M 2025-09
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Coherus Biosciences USD 62.44M 59.9M 2025-03
Eli Lilly USD 19.46B 2.25B 2025-09
Fujifilm JPY 822.64B 36.85B 2025-12
Gilead Sciences USD 5.1B 314M 2025-09
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Merck USD 12.12B 596M 2025-09
Myriad Genetics USD 118M 19M 2025-09
Pacira USD 115.27M 901K 2025-09
Perrigo USD 644.4M 62.2M 2025-09
Pfizer USD 18.12B 2.02B 2025-09
PTC Therapeutics USD 203.07M 6.94M 2025-09
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Sarepta Therapeutics USD 395.74M 213.86M 2025-09
Teva Pharmaceutical Industries USD 3.71B 101M 2025-12
Vertex Pharmaceuticals USD 1.95B 52.9M 2025-09
Xencor USD 21.8M 25.75M 2025-09
Zoetis USD 1.54B 1000K 2025-09


Coherus Biosciences Devedores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.